Ani Pharmaceuticals, Inc
$1.63B- Market cap
- $1.60B
- Debt
- +$309.11M
- Cash
- −$285.59M
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIP · current priceP/E 21.45x
$71.23Latest market snapshot
Implied fair value · at CART's multiple
$105.9748.8% above market
3.32 ANIP EPS (TTM)×31.92x CART P/E=$105.97
Market $71.23Implied $105.97
CART · current priceP/E 31.92x
$51.07Latest market snapshot
Implied fair value · at ANIP's multiple
$34.3332.8% below market
1.60 CART EPS (TTM)×21.45x ANIP P/E=$34.33
Market $51.07Implied $34.33